Belgium's Prime Minister Bart de Wever attends the opening of a new centre dedicated to accelerating vaccine development of British pharmaceutical company GSK in Rixensart, on June 9, 2026. The British pharmaceutical giant GSK opens a new research centre in Belgium and also announced on June 9, 2026, that it had reached an agreement to acquire the US biopharmaceutical company Nuvalent, which specialises in the development of cancer therapies, "for $10.6 billion" (9.18 billion). (Photo by ERIC LALMAND / POOL / AFP via Getty Images) / Belgium OUT

This photograph shows the logo of British pharmaceutical company GSK on a facade during the opening of a new centre dedicated to accelerating vaccine development in Rixensart, on June 9, 2026. The British pharmaceutical giant GSK opens a new research centre in Belgium and also announced on June 9, 2026, that it had reached an agreement to acquire the US biopharmaceutical company Nuvalent, which specialises in the development of cancer therapies, "for $10.6 billion" (9.18 billion). (Photo by ERIC LALMAND / Belga / AFP via Getty Images) / Belgium OUT

This aerial photograph shows a view of British pharmaceutical company GSK's new centre dedicated to accelerating vaccine development in Rixensart, on June 9, 2026. The British pharmaceutical giant GSK opens a new research centre in Belgium and also announced on June 9, 2026, that it had reached an agreement to acquire the US biopharmaceutical company Nuvalent, which specialises in the development of cancer therapies, "for $10.6 billion" (9.18 billion). (Photo by ERIC LALMAND / Belga / AFP via Getty Images) / Belgium OUT

This photograph shows the logo of British pharmaceutical company GSK on an entrance during the opening of a new centre dedicated to accelerating vaccine development in Rixensart, on June 9, 2026. The British pharmaceutical giant GSK opens a new research centre in Belgium and also announced on June 9, 2026, that it had reached an agreement to acquire the US biopharmaceutical company Nuvalent, which specialises in the development of cancer therapies, "for $10.6 billion" (9.18 billion). (Photo by ERIC LALMAND / Belga / AFP via Getty Images) / Belgium OUT

This photograph shows the logo of British pharmaceutical company GSK on an entrance during the opening of a new centre dedicated to accelerating vaccine development in Rixensart, on June 9, 2026. The British pharmaceutical giant GSK opens a new research centre in Belgium and also announced on June 9, 2026, that it had reached an agreement to acquire the US biopharmaceutical company Nuvalent, which specialises in the development of cancer therapies, "for $10.6 billion" (9.18 billion). (Photo by ERIC LALMAND / Belga / AFP via Getty Images) / Belgium OUT

This photograph shows the logo of British pharmaceutical company GSK on an entrance during the opening of a new centre dedicated to accelerating vaccine development in Rixensart, on June 9, 2026. The British pharmaceutical giant GSK opens a new research centre in Belgium and also announced on June 9, 2026, that it had reached an agreement to acquire the US biopharmaceutical company Nuvalent, which specialises in the development of cancer therapies, "for $10.6 billion" (9.18 billion). (Photo by ERIC LALMAND / Belga / AFP via Getty Images) / Belgium OUT

A vendor offers apricots at a market place in Moscow on June 9, 2026. Effective June 2, 2026, Russia has completely banned the import of apricots from Armenia. The restriction also applies to transit through the Russian Federation and affects other stone fruits (cherries, plums, peaches) and a number of other fruits and vegetables. More than 90% of Armenia's apricot exports went to Russia till now. Armenian Prime Minister Nikol Pashinyan's efforts to free Armenia from the influence of its former imperial ruler have angered the Kremlin, which claims the West influenced the election results and the authorities pressured the opposition. (Photo by Alexander NEMENOV / AFP via Getty Images)

A vendor offers apricots at a market place in Moscow on June 9, 2026. Effective June 2, 2026, Russia has completely banned the import of apricots from Armenia. The restriction also applies to transit through the Russian Federation and affects other stone fruits (cherries, plums, peaches) and a number of other fruits and vegetables. More than 90% of Armenia's apricot exports went to Russia till now. Armenian Prime Minister Nikol Pashinyan's efforts to free Armenia from the influence of its former imperial ruler have angered the Kremlin, which claims the West influenced the election results and the authorities pressured the opposition. (Photo by Alexander NEMENOV / AFP via Getty Images)